Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This phase Ⅰ/Ⅱ trial is designed to explore a higher radiation dose by using IMRT
simultaneous integrated boost technique with or without concurrent chemotherapy for locally
advanced esophageal carcinoma.